Withaferin A ameliorates psoriasis-like skin lesions by suppressing oxidative stress in keratinocytes.
Saved in:
| Title: | Withaferin A ameliorates psoriasis-like skin lesions by suppressing oxidative stress in keratinocytes. |
|---|---|
| Authors: | Zhang MY; Department of Basic Medicine, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Liu YC; Department of Basic Medicine, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Liu XY; Department of Basic Medicine, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Chen DW; Department of Basic Medicine, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Han C; Department of Basic Medicine, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Shen X; Department of Basic Medicine, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Ding YX; Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China., Wang XP; Department of Basic Medicine, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Shi AP; Department of Pharmacy, Taixing People's Hospital, Taixing 225400, China. |
| Source: | Journal of Asian natural products research [J Asian Nat Prod Res] 2026 Feb; Vol. 28 (2), pp. 310-322. Date of Electronic Publication: 2025 Apr 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 100888334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2213 (Electronic) Linking ISSN: 10286020 NLM ISO Abbreviation: J Asian Nat Prod Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
